Repair Biotechnologies
Repair Biotechnologies is a biotechnology company with the mission to develop and bring to the clinic therapies.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $8.4m | Early VC |
| Total Funding | 000k | ||
Related Content
Repair Biotechnologies, founded in 2018 by Reason and Bill Cherman, is a biotechnology company focused on developing therapies to combat age-related diseases and extend human healthspan. The company operates in the longevity sector, aiming to address the root causes of aging through innovative medical treatments. Repair Biotechnologies targets conditions such as atherosclerosis and thymus atrophy, which are significant contributors to aging and related diseases. The company serves a broad market that includes healthcare providers, research institutions, and potentially aging individuals seeking to improve their quality of life.
Repair Biotechnologies' business model revolves around research and development, clinical trials, and eventual commercialization of their therapies. Revenue is generated through partnerships, grants, and future sales of approved treatments.
Keywords: longevity, healthspan, aging, atherosclerosis, thymus atrophy, biotechnology, therapies, clinical trials, healthcare, innovation.